Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$57.1M |
| 2 |
Veralto
VLTO
|
+$54.6M |
| 3 |
Newmont
NEM
|
+$40.4M |
| 4 |
Vertiv
VRT
|
+$17.2M |
| 5 |
Webster Financial
WBS
|
+$14.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$314M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$237M |
| 3 |
Microsoft
MSFT
|
+$231M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.88% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.38% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
ICF International
ICFI
$1.57B
| $4.97M | ﹤0.01% |
37,100
-4,200
| -10% | -$552K |
|
1302
Cable One
CABO
$198M
| $4.95M | ﹤0.01% |
8,900
-1,100
| -11% | -$628K |
|
1303
Madrigal Pharmaceuticals
MDGL
$11.9B
| $4.95M | ﹤0.01% |
21,400
-700
| -3% | -$122K |
|
1304
LiveRamp
RAMP
$2.3B
| $4.94M | ﹤0.01% |
130,500
-15,900
| -11% | -$511K |
|
1305
Simmons First National
SFNC
$3.47B
| $4.94M | ﹤0.01% |
248,886
-31,000
| -11% | -$519K |
|
1306
Braze
BRZE
$3.12B
| $4.93M | ﹤0.01% |
92,700
+1,400
| +2% | +$69.2K |
|
1307
Griffon
GFF
$4.8B
| $4.92M | ﹤0.01% |
80,800
-13,500
| -14% | -$624K |
|
1308
Papa John's
PZZA
$812M
| $4.92M | ﹤0.01% |
64,600
-7,200
| -10% | -$490K |
|
1309
Flywire
FLYW
$2.14B
| $4.88M | ﹤0.01% |
210,700
+19,200
| +10% | +$484K |
|
|
MRTX
1310
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.88M | ﹤0.01% |
83,000
-28,800
| -26% | -$1.62M |
|
1311
TG Therapeutics
TGTX
$7.38B
| $4.83M | ﹤0.01% |
282,600
-29,400
| -9% | -$342K |
|
|
PDCO
1312
DELISTED
Patterson Companies, Inc.
PDCO
| $4.83M | ﹤0.01% |
169,600
-18,900
| -10% | -$556K |
|
1313
Axsome Therapeutics
AXSM
$11.3B
| $4.82M | ﹤0.01% |
60,500
-11,200
| -16% | -$749K |
|
|
PRMW
1314
DELISTED
Primo Water Corporation
PRMW
| $4.81M | ﹤0.01% |
318,548
-31,600
| -9% | -$451K |
|
1315
Graham Holdings Company
GHC
$4.99B
| $4.81M | ﹤0.01% |
6,900
-1,000
| -13% | -$622K |
|
1316
Plug Power
PLUG
$3.23B
| $4.8M | ﹤0.01% |
1,067,688
-120,400
| -10% | -$631K |
|
1317
Highwoods Properties
HIW
$3.51B
| $4.78M | ﹤0.01% |
208,302
-23,600
| -10% | -$470K |
|
1318
National Health Investors
NHI
$3.52B
| $4.78M | ﹤0.01% |
85,620
-9,700
| -10% | -$514K |
|
1319
Stride
LRN
$3.41B
| $4.78M | ﹤0.01% |
80,500
-9,400
| -10% | -$515K |
|
1320
Seacoast Banking Corp of Florida
SBCF
$3.47B
| $4.77M | ﹤0.01% |
167,700
-18,300
| -10% | -$431K |
|
1321
Amphastar Pharmaceuticals
AMPH
$858M
| $4.77M | ﹤0.01% |
77,100
-7,800
| -9% | -$410K |
|
1322
Douglas Emmett
DEI
$1.98B
| $4.76M | ﹤0.01% |
328,600
-44,700
| -12% | -$567K |
|
|
CVSA
1323
Covista Inc
CVSA
$4.53B
| $4.76M | ﹤0.01% |
80,800
-15,000
| -16% | -$800K |
|
1324
MYR Group
MYRG
$5.21B
| $4.76M | ﹤0.01% |
32,900
-3,900
| -11% | -$502K |
|
|
CWAN
1325
DELISTED
Clearwater Analytics
CWAN
| $4.76M | ﹤0.01% |
237,500
+64,500
| +37% | +$1.27M |
|
Similar funds
Swiss National Bank's Q4 2023 Portfolio in Review
As of Q4 2023, Swiss National Bank held 2,646 positions worth $136B, up 6.9% from $127B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank withdrew a net $4.96B in Q4 2023, closing 112 positions and reducing 2,341 holdings. Its most notable exit was Activision Blizzard, an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Veralto worth $60.2M.
- Swiss National Bank's largest Q4 2023 buy was Veralto: 731,669 shares worth $60.2M.
- Swiss National Bank added most to Broadcom in Q4 2023, an estimated $57.1M increase.
- Swiss National Bank's biggest Q4 2023 reduction was Apple, cutting an estimated $314M.
- Swiss National Bank fully exited Activision Blizzard in Q4 2023, selling an estimated $237M.
- Swiss National Bank's ten largest holdings make up 28% of its $136B portfolio in Q4 2023.
- Swiss National Bank opened 38 new positions and closed 112 in Q4 2023.
- Swiss National Bank's portfolio value rose 6.9% quarter-over-quarter to $136B.
Based on Swiss National Bank's 13F filing for Q4 2023, filed 6 Feb 2024.